FDA Proposing to Ease DTC Genetic Tests’ Path to Market
The US Food and Drug Administration (FDA) is proposing to ease the approval process for direct-to-consumer genetic tests, saying that the diagnostics can increase consumer engagement in their health. “In its consideration of [genetic health risk] tests, the FDA seeks to strike a balance that provides for an efficient pathway to bring these tests to …
FDA Proposing to Ease DTC Genetic Tests’ Path to Market Read More »